Your search returned 7 results.

Results
	1.	Real-world predictors of 12-month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study. [electronic resource] by Alten, Rieke Mariette, Xavier Lorenz, Hanns-Martin Galeazzi, Mauro Cantagrel, Alain Nüßlein, Hubert G Chartier, Melanie Elbez, Yedid Rauch, Christiane Le Bars, Manuela Publication details: RMD open 2017 In: RMD open vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Baseline autoantibodies preferentially impact abatacept efficacy in patients with rheumatoid arthritis who are biologic naïve: 6-month results from a real-world, international, prospective study. [electronic resource] by Alten, Rieke Nüßlein, Hubert G Mariette, Xavier Galeazzi, Mauro Lorenz, Hanns-Martin Cantagrel, Alain Chartier, Melanie Poncet, Coralie Rauch, Christiane Le Bars, Manuela Publication details: RMD open 2017 In: RMD open vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study. [electronic resource] by Mariette, Xavier Alten, Rieke Nüßlein, Hubert G Galeazzi, Mauro Lorenz, Hanns-Martin Cantagrel, Alain Chartier, Melanie Poncet, Coralie Rauch, Christiane Le Bars, Manuela Producer: 20180614 In: Joint bone spine vol. 84 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Retention and clinical response to abatacept in patients with rheumatoid arthritis: an Italian perspective. [electronic resource] by Galeazzi, Mauro Alten, Rieke Chartier, Melanie Elbez, Yedid Fusaro, Enrico Le Bars, Manuela Lorenz, Hanns-Martin Pagano Mariano, Giuseppa Muratore, Maurizio Nüßlein, Hubert G Patanè, Giovanni Producer: 20190107 In: Clinical and experimental rheumatology vol. 36 Availability: No items available. Save to lists Add to cart (remove)
	5.	Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study. [electronic resource] by Nüßlein, Hubert G Alten, Rieke Galeazzi, Mauro Lorenz, Hanns-Martin Nurmohamed, Michael T Bensen, William G Burmester, Gerd R Peter, Hans-Hartmut Pavelka, Karel Chartier, Melanie Poncet, Coralie Rauch, Christiane Le Bars, Manuela Producer: 20160401 In: BMC musculoskeletal disorders vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study. [electronic resource] by Nüßlein, Hubert G Alten, Rieke Galeazzi, Mauro Lorenz, Hanns-Martin Nurmohamed, Michael T Bensen, William G Burmester, Gerd R Peter, Hans-Hartmut Peichl, Peter Pavelka, Karel Chartier, Mélanie Poncet, Coralie Rauch, Christiane Le Bars, Manuela Producer: 20160805 In: Clinical and experimental rheumatology vol. 34 Availability: No items available. Save to lists Add to cart (remove)
	7.	Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study. [electronic resource] by Nüßlein, Hubert G Alten, Rieke Galeazzi, Mauro Lorenz, Hanns-Martin Boumpas, Dimitrios Nurmohamed, Michael T Bensen, William G Burmester, Gerd R Peter, Hans-Hartmut Rainer, Franz Pavelka, Karel Chartier, Melanie Poncet, Coralie Rauch, Christiane Bars, Manuela Le Producer: 20140929 In: BMC musculoskeletal disorders vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)